Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2006
07/11/2006US7074821 Taxoids, their preparation and pharmaceutical composition containing them
07/11/2006US7074820 Amidino derivatives and their use as thrombin inhibitors
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074818 Anticholesterol agents; reacting atorvastatin with calcium acetate; salt formation; heating; filtration; distillation
07/11/2006US7074817 For treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis
07/11/2006US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide
07/11/2006US7074815 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body
07/11/2006US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis
07/11/2006US7074813 Antiproliferation agent; antiumor, anticancer agents
07/11/2006US7074812 Concurrent administering nicotine or nicotine acetylcholine receptors antagonist with exercise
07/11/2006US7074811 for use in the treatment and/or prophylaxis of diabetes mellitus
07/11/2006US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
07/11/2006US7074809 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor
07/11/2006US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
07/11/2006US7074807 Compositions and methods for inducing cell death
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
07/11/2006US7074804 CCI-779 Isomer C
07/11/2006US7074803 Fentanyl, or compound thereof; reducing pain
07/11/2006US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074798 Xanthine derivative and DPPIV inhibitor
07/11/2006US7074797 Pyrazolopyrimidines as CRF receptor antagonists
07/11/2006US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder.
07/11/2006US7074795 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides
07/11/2006US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease
07/11/2006US7074791 Pyrrolo[1,2-b]pyridazine compounds and their uses
07/11/2006US7074790 Antiinflammatory agents; autoimmune disease
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics
07/11/2006US7074786 Histogranin-like peptides, processes for their preparation and uses thereof
07/11/2006US7074784 Medicaments against viral diseases
07/11/2006US7074783 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders
07/11/2006US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor
07/11/2006US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders.
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006US7074779 Osteoporosis; menopause; breast cancer; endometriosis; contraceptiives
07/11/2006US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
07/11/2006US7074777 Vitamin D derivatives
07/11/2006US7074776 Exposing bacterium to heterocyclic comound for controlling growth
07/11/2006US7074775 Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
07/11/2006US7074774 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia
07/11/2006US7074773 Pharmaceutical composition for diabetic neuropathy
07/11/2006US7074771 Gene encoding MNR2 and uses thereof
07/11/2006US7074770 Administering to a mammal a vector or nucleotide sequence which code an antigenic peptide; together with Schiff base
07/11/2006US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer
07/11/2006US7074768 Modified protein kinase A-specific oligonucleotides and methods of their use
07/11/2006US7074762 Contacting metanephric tissue with a growth factor-containing formulation comprising one or more growth factors for metanephric development for therapy of metanephric tissue that is transplanted into a recipient
07/11/2006US7074742 Pyridinyl amides and imides for use as fungicides
07/11/2006US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells
07/11/2006US7074601 Nucleozymes
07/11/2006US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian
07/11/2006US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies
07/11/2006US7074440 Herbal plant extracts
07/11/2006US7074438 Compositions for oral delivery of nutrients and pharmaceuticals
07/11/2006US7074437 comprises synthetic zeolite, protein extracts of nettle, milk vetch, balm, hop cones, and B-complex vitamins
07/11/2006US7074436 Method for the production of phyllanthus extracts
07/11/2006US7074432 Drug , biocompatible polymer and biphosphonate compound
07/11/2006US7074431 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil
07/11/2006US7074430 Oral administering
07/11/2006US7074429 Using stearic acid or zinc stearate as lubricant
07/11/2006US7074427 Comprises a shell with a gas enclosed in the internal space thereof as well as a substance capable of generating active oxygen species upon irradiation of the shell with an ultrasound as retained or contained in shell; therapy
07/11/2006US7074425 Hemostatic compositions and methods
07/11/2006US7074420 Cosmetic treatment using a new retinoid
07/11/2006US7074418 Conjugated fatty acid based emulsion and methods for preparing and using same
07/11/2006US7074412 For therapy of orthopaedic and dental, including periodontal, diseases
07/11/2006US7074411 α-β C4BP-type recombinant heteromultimeric proteins
07/11/2006US7074406 Treating allergic diseases with humanized anti-CD40L antibody
07/11/2006US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells
07/11/2006US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
07/11/2006US7074392 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent
07/11/2006US7074391 Use of olive oil in the preparation of a product for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in the mouth
07/11/2006US7074389 For therapy and prophylaxis, side effect reduction
07/11/2006US7074388 Water stabilized medicinal aerosol formulation
07/11/2006US7074385 IM-12 crystallized solid and its process of preparation
07/11/2006US7073512 Adhesion prevention and an endoscopic insufflation system therefor
07/11/2006CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors
07/11/2006CA2390952C Compositions and process for retaining active ingredients comprising networked structured polymers
07/11/2006CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them
07/11/2006CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them
07/11/2006CA2364824C Anti-bacterial composition to be diffused to fight bacteria contained in the air and the process for diffusing such a composition
07/11/2006CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders
07/11/2006CA2363933C Capsule system
07/11/2006CA2355102C Antiparasitic formulations comprising doramectin
07/11/2006CA2351658C Anticonvulsant derivatives useful in treating post traumatic stress disorder
07/11/2006CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them
07/11/2006CA2341375C Extended release buccal bioadhesive tablet
07/11/2006CA2325779C New derivatives of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbzole and 12,13 (pyranosyl)-furo[3,4-c]indol[2,3-a]carbazole, their preparation process and the pharmaceutical compositions therein
07/11/2006CA2319201C Celecoxib compositions
07/11/2006CA2298704C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
07/11/2006CA2295389C Method of treatment of nausea, vomiting, and other disorders using estrogens
07/11/2006CA2294670C Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
07/11/2006CA2293793C Rapamycin formulations for oral administration
07/11/2006CA2290830C Process
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2283829C 2-alkylidene-19-nor-vitamin d compounds